US Patent 10202365 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
Patent 10202365 was granted and assigned to Blueprint Medicines on February, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10202365 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
